| Code | 50087 | ||||||||||
| MA number | 24/0164/08-S | ||||||||||
| Product Form: | tbl flm 30x5 mg (bli. OPA/Al/PVD/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
| Therapeutic Class: | 24 - ANTIHISTAMINICA, HISTAMIN | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 23.04.2008 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Cezera 5 mg_tbl flm_03/2024.pdf
|
| SPC: |
SPC_Cezera 5 mg_tbl flm_03/2024.pdf
|
| Safety feature | Yes |
| Data update: | 16.04.2018 |
